Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta‐Analysis
Liver International · 2026-06 · 46 (6)
DOI: 10.1111/liv.70673 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Liver International, online erschienen am 21.05.2026. Verfasst von Isabelle Castro Vitor und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Liver Transplantation, Cholangitis, Sclerosing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Primary sclerosing cholangitis (PSC) is an immune‐mediated cholestatic liver disease. Liver transplantation (LT) remains the only definitive treatment for patients with advanced disease. However, recurrence of PSC (rPSC) after LT is still a significant clinical challenge. The aim of this study was to assess the prevalence and incidence of rPSC following transplantation and to identify factors associated with its occurrence.
Methods
We conducted a systematic review and meta‐analysis of observational cohorts by searching PubMed, Embase and Cochrane for studies. Statistical analyses were conducted using R, applying a random‐effects model with 95% confidence intervals.
Results
Twenty‐nine studies were included, comprising 4682 patients who underwent LT for PSC (63.7% male). Most data originated from Europe (51.7%) and North America (29.2%), with additional cohorts from Asia (13.7%), South America (2.8%) and Oceania (2.6%). The worldwide pooled prevalence of rPSC was 18.66% (95% CI 15.33–22.52; I 2 = 84%) between 1980 and 2024. As for the worldwide pooled incidence, rPSC occurred at 26.04 per 1000 person‐years (95% CI 19.30–32.78; I 2 = 76.1%). The continent with the highest rPSC prevalence was Oceania with 30.65% (95% CI 23.17–39.29; I 2 = 13.8%) and South America had the highest incidence with 39.97 per 1000 person‐years (95% CI 25.42–54.51). Younger recipient age (mean difference [MD] = 5.16 years, 95% CI 4.13–6.19; I 2 = 51.3%), male sex (risk ratio [RR] = 0.92, 95% CI 0.87–0.98; I 2 = 0%), post‐LT cyclosporine use (RR = 0.56, 95% CI 0.42–0.76; I 2 = 0%), acute rejection (RR = 0.64, 95% CI 0.49–0.83) and de novo IBD (RR = 0.63, 95% CI 0.40–0.99; I 2 = 0%) were associated with an increased risk of recurrence.
Conclusions
Prevalence and incidence of rPSC post‐LT varied according to continents. Younger recipient age, male sex, de novo IBD, cyclosporine use post‐LT and acute rejection episodes were associated with a higher risk of recurrence. Trial Registration PROSPERO ID: CRD420250645485
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Federal University of the State of Rio de Janeiro, Rio de Janeiro, Brazil.
- Department of Medicine, Federal University of Campina Grande Faculty of Medicine, Cajazeiras, Brazil.
- Department of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Brazil.
- Center of Medical Sciences, Federal University of Paraíba, João Pessoa, Brazil.
- Department of Medicine, Federal University of Ceará, Fortaleza, Brazil.
- Department of Medicine, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
ORCID-Profile: Isabelle Castro Vitor, Milena Ramos Tomé, Wellgner Fernandes Oliveira Amador, Igor Boechat Silveira, Marina de Assis Bezerra Cavalcanti Leite, Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Yohanna Idsabella Rossi, Guilherme Grossi Lopes Cançado, Rodrigo Vieira Motta
Zitieren
APA
Vitor, I. C., Tomé, M. R., Amador, W. F. O., Silveira, I. B., Leite, M. A. B. C., Passos, P. R. C., Filho, V. O. C., Noronha, M. M., Rossi, Y. I., Cançado, G. G. L., & Motta, R. V. (2026). Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta‐Analysis. Liver International, 46(6). https://doi.org/10.1111/liv.70673
Vancouver
Vitor IC, Tomé MR, Amador WFO, Silveira IB, Leite MABC, Passos PRC, et al. Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta‐Analysis. Liver International. 2026;46(6). doi:10.1111/liv.70673
BibTeX
@article{Vitor2026,
author = {Vitor, Isabelle Castro and Tomé, Milena Ramos and Amador, Wellgner Fernandes Oliveira and Silveira, Igor Boechat and Leite, Marina de Assis Bezerra Cavalcanti and Passos, Pedro Robson Costa and Filho, Valbert Oliveira Costa and Noronha, Mariana Macambira and Rossi, Yohanna Idsabella and Cançado, Guilherme Grossi Lopes and Motta, Rodrigo Vieira},
title = {Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta‐Analysis},
journal = {Liver International},
year = {2026},
volume = {46},
number = {6},
doi = {10.1111/liv.70673}
}
EUVIMED